Rare lephants
Screener

PRELUDE THERAPEUTICS INC

PRLD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Apr 29, 2021 FORM 4 SUBMISSION
DEFA14A Apr 29, 2021 DEFA14A
DEF 14A Apr 29, 2021 DEF 14A
4 Apr 21, 2021 FORM 4 SUBMISSION
4 Apr 15, 2021 FORM 4 SUBMISSION
4 Apr 15, 2021 FORM 4 SUBMISSION
4 Apr 15, 2021 FORM 4 SUBMISSION
4 Apr 15, 2021 FORM 4 SUBMISSION
4 Apr 9, 2021 FORM 4 SUBMISSION
4 Apr 9, 2021 FORM 4 SUBMISSION
4 Apr 9, 2021 FORM 4 SUBMISSION
4 Apr 9, 2021 FORM 4 SUBMISSION
8-K Mar 17, 2021 8-K
S-8 Mar 16, 2021 S-8
10-K Mar 16, 2021 10-K
8-K Mar 16, 2021 8-K
8-K Mar 8, 2021 8-K
SC 13G Feb 11, 2021 SC 13G
SC 13G/A Feb 10, 2021
SC 13G Feb 8, 2021
4 Jan 29, 2021 PRIMARY DOCUMENT
SC 13D/A Jan 29, 2021 SCHEDULE 13D/A
8-K Jan 28, 2021 8-K
SC 13D/A Jan 14, 2021 AMENDMENT NO. 1
4 Jan 13, 2021 PRIMARY DOCUMENT
← Newer Page 13 of 16 · 389 filings Older →